Please assess the completion status of the following clinical trial:

Trial Title: Study to Investigate Real Life Effectiveness of Symbicort Maintenance and Reliever Therapy in Asthma Patients Across Asia

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Provision of signed informed consent~* Asthma diagnosis at least 6 months before visit 1 of study~* Patients who have reversible airway obstruction continuous asthma treatment except Symbicort at least within 4 weeks before visit 1 of study~Exclusion Criteria:~* Known or suspected allergy to active ingredients of study medication or excipients~* Use of oral, rectal or parenteral glucocorticosteroids 30 days before visit 1 of study~* Smoking, current or previous with a smoking history of ≥ 10 pack years

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Symbicort Turbuhaler 160/4.5 µg delivered dose

Based on this trial design, predict the completion outcome and termination type (if applicable).